Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Autoimmune Disorders

  Free Subscription


03.08.2026

1 Ann Neurol
1 BMC Neurol
2 Diabetes
1 J Immunol
1 J Neuroimmunol
1 J Neurol
1 Kidney Int
1 Mult Scler
2 N Engl J Med
2 Neurology
4 PLoS One
1 Proc Natl Acad Sci U S A
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. AMEZCUA L, Reder AT, Bernitsas E, Monson NL, et al
    Two Years of Ocrelizumab Treatment in Black and Hispanic People with Multiple Sclerosis in CHIMES: A Single-Arm Clinical Trial.
    Ann Neurol. 2026 Jul 30. doi: 10.1002/ana.78290.
    PubMed         Abstract available


    BMC Neurol

  2. YIN H, Hao M, Xu Y
    Patient-reported outcomes in Chinese patients with AQP4-IgG-positive neuromyelitis optica spectrum disorder on inebilizumab therapy: a cross-sectional study.
    BMC Neurol. 2026;26:484.
    PubMed         Abstract available


    Diabetes

  3. ZHANG J, Li M, Zhou X, Ni H, et al
    Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization.
    Diabetes. 2026 Jul 31:db260365. doi: 10.2337/db26-0365.
    PubMed         Abstract available

  4. BURKETT JB, Fuhr J, Falk AC, Dadi P, et al
    Dual Modulation of Prostaglandin E2 Receptors EP3 and EP4 Protects beta-Cell Mass in a Model of Aggressive Autoimmune Inflammation.
    Diabetes. 2026 Jul 31:db251007. doi: 10.2337/db25-1007.
    PubMed         Abstract available


    J Immunol

  5. PRADO DE MAIO D, Tetteh S, Ayers C, St Martin A, et al
    Lowering CD40L expression in murine lupus results in an increase in disease indicators in female but not male B6 mice.
    J Immunol. 2026;215:vkag205.
    PubMed         Abstract available


    J Neuroimmunol

  6. MAUCERI VA, Di Mare D, Rinaldi F, Di Paola A, et al
    Lesion burden determines the incremental diagnostic value of intrathecal IgG oligoclonal bands synthesis in multiple sclerosis.
    J Neuroimmunol. 2026;420:579045.
    PubMed         Abstract available


    J Neurol

  7. ACHILLE M, Copetti M, Guerra T, Ferri C, et al
    Prognostic factors in paediatric-onset multiple sclerosis: a narrative review.
    J Neurol. 2026;273:495.
    PubMed         Abstract available


    Kidney Int

  8. LICHTNEKERT J, Anders HJ
    Triple therapy is not required for all newly diagnosed cases of lupus nephritis.
    Kidney Int. 2028 Jun 16:S0085-2538(26)00507-7. doi: 10.1016/j.kint.2026.
    PubMed        


    Mult Scler

  9. SHIPLEY J, Zhu C, Sanfilippo PG, Skibina O, et al
    Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.
    Mult Scler. 2026 Jul 29:13524585261464055. doi: 10.1177/13524585261464055.
    PubMed         Abstract available


    N Engl J Med

  10. SCHETT G, Wirsching A, Rothe T, Visconti V, et al
    Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.
    N Engl J Med. 2026 Jul 29. doi: 10.1056/NEJMc2607737.
    PubMed        

  11. WARKENTIN TE, Greinacher A
    Platelet-Activating Anti-Platelet Factor 4 Disorders.
    N Engl J Med. 2026 Jul 13. doi: 10.1056/NEJMra2502459.
    PubMed         Abstract available


    Neurology

  12. SCHOOF L, Heijnen R, Hogenboom L, Van Kempen ZLE, et al
    Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis.
    Neurology. 2026;107:e218379.
    PubMed         Abstract available

  13. MOHAMED MI, Sameh R, Farghaly D, Ashraf B, et al
    Autoimmune Neurologic Disorders and the Risk of Alzheimer, Vascular, and Other Dementias: A Comprehensive Systematic Review and Meta-Analysis (P2-13.006).
    Neurology. 2026;107:e218536.
    PubMed        


    PLoS One

  14. ZHU K, Barberio J, Tsao N, Mor A, et al
    Trends in the incidence of asthma, atopic dermatitis, and multiple sclerosis before, during, and after the COVID-19 pandemic in a US claims database.
    PLoS One. 2026;21:e0355103.
    PubMed         Abstract available

  15. WU S, Wu Y, Zhang L, Zhu J, et al
    Bisphenol A exposure in myasthenia gravis: Potential targets and mechanisms revealed by network toxicology and molecular dynamics.
    PLoS One. 2026;21:e0354138.
    PubMed         Abstract available

  16. FIGUEIREDO DS, Martinez ARM, Nucci A, Franca Junior MC, et al
    Myasthenia gravis: Diagnostic journey and therapeutic outcomes in patients followed at a Brazilian public tertiary center - A retrospective cohort study.
    PLoS One. 2026;21:e0353883.
    PubMed         Abstract available

  17. DE HERDT D, Lefevere E, Brouwers V, Hartvig L, et al
    Selective GPR17 antagonism enhances structural and functional recovery in animal models of demyelination.
    PLoS One. 2026;21:e0354525.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  18. GERVAIS A, Marchal A, Maillard A, Le Voyer T, et al
    High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.
    Proc Natl Acad Sci U S A. 2026;123:e2518581123.
    PubMed         Abstract available


    Thyroid

  19. PEREZ-LOPEZ M, Perros P
    Graves' Orbitopathy and Anophthalmia.
    Thyroid. 2026 Jul 29:10507256261473411. doi: 10.1177/10507256261473411.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum